NCT02420249

Brief Summary

Objectives: (1) To investigate the effects of Qigong training on upper limb oedema, circulatory status, shoulder flexibility and muscular strength, body balance, and quality of life (QOL) in community-dwelling breast cancer survivors; and (2) to explore the relationship between the impairment outcomes and QOL outcomes. Hypothesis: (1) The experimental participants will have less impairment and a better QOL after Qigong training compared with the no-training control group; and (2) the impairment parameters will be related to the QOL indexes in the Qigong participants. Design and subjects: This will be a prospective, randomised, single-blinded controlled trial. Approximately 60 breast cancer survivors will be randomly assigned to either the Qigong training group (n\~30) or control group (n\~30). Intervention: Participants in the Qigong group will receive 18 Forms of Tai Chi Internal Qigong training for 3 months with two supervised 1-hour sessions per week. Main outcome measures: The primary outcome measures are upper limb circumference, arterial blood flow velocities and resistance index, shoulder joint passive range of motion, muscular strength (peak force) and body balance. The secondary outcome measure is quality of life as measured by the Functional Assessment of Cancer Therapy - Breast scale. Data analysis: Data will be analysed via repeated-measures analysis of variance followed by post-hoc tests (α = 0.05). Expected results: The investigators pilot studies produced encouraging results on the efficacy of Qigong exercise in reducing chronic breast cancer-related symptoms in survivors. Therefore, the investigators expect that participants in the Qigong group will have fewer upper limb impairments and a better quality of life after Qigong training. If the results are positive, this Qigong training regime is readily transferrable to clinical practice, and could have positive socioeconomic effects such as reduced healthcare costs.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 9, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 17, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Last Updated

December 15, 2015

Status Verified

December 1, 2015

Enrollment Period

2.2 years

First QC Date

April 9, 2015

Last Update Submit

December 13, 2015

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change in upper limb circumference

    Circumference of both arms will be measured using a cloth measuring tape.

    Baseline (0 month) and post-intervention (3 months)

  • Change in arterial resistance and blood flow velocities

    A Doppler ultrasound machine will be used to examine the arterial blood flow velocities.

    Baseline (0 month) and post-intervention (3 months)

  • Change in shoulder flexibility

    A universal goniometer will be used to measure the passive range of motion (ROM) of bilateral shoulder abduction and horizontal abduction.

    Baseline (0 month) and post-intervention (3 months)

  • Change in shoulder muscular strength

    The maximum isometric muscular strength of the shoulder flexor, abductor, internal rotator and external rotator muscles will be measured bilaterally using the Lafayette Manual Muscle Test System.

    Baseline (0 month) and post-intervention (3 months)

  • Change in body balance

    Standing balance of the participants will be measured using timed single leg standing test.

    Baseline (0 month) and post-intervention (3 months)

Secondary Outcomes (1)

  • Change in quality of life

    Baseline (0 month) and post-intervention (3 months)

Study Arms (2)

Qigong training group

EXPERIMENTAL

Participants assigned to the Qigong group will receive Qigong training. The Qigong training programme will be run for 3 months with two supervised 1-hour sessions per week. Participants will learn the 18 Forms of Tai Chi Internal Qigong. The training sessions will be conducted by a qualified Qigong instructor from the Natural Health Qigong Association. Participants in the control group will receive no Qigong training during the study period. They will receive an 18 Forms of Tai Chi Internal Qigong training package after the study.

Behavioral: Qigong training

Control group

NO INTERVENTION

Participants in the control group will receive no Qigong training.

Interventions

Qigong trainingBEHAVIORAL

Participants will learn the 18 Forms of Tai Chi Internal Qigong. Detailed movement and breathing descriptions of the Qigong training protocol can been found in Mak YK. 18 Forms Tai Chi Qigong \[in Chinese\]. 7th ed. Hong Kong: Wan Li Book Co.; 2012.

Qigong training group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • history of a breast malignancy of any stage
  • history of mastectomy or lumpectomy with or without adjuvant chemotherapy or radiotherapy
  • having completed conventional cancer treatment and medically stable
  • no known neurological deficits resulting from breast cancer treatment or other neurological disorders
  • persistent lymphoedema defined as a circumference difference greater than 2 cm at any point between the surgical upper limb and contralateral upper limb13
  • female aged 18 or above.

You may not qualify if:

  • presence of major psychiatric, neurological, musculoskeletal, cardiovascular, peripheral vascular or kidney disorder
  • receiving conventional cancer treatments such as chemotherapy or radiotherapy, medications such as diuretics or traditional Chinese medicine
  • recurrent cancer or cancer that has spread to another organ
  • participation in regular physical activity
  • prior experience of Qigong or Tai Chi
  • a smoking habit
  • pregnancy during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Hong Kong

Pokfulam, Hong Kong

RECRUITING

MeSH Terms

Conditions

Neoplasms

Central Study Contacts

Shirley SM Fong, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, DRPC chairperson

Study Record Dates

First Submitted

April 9, 2015

First Posted

April 17, 2015

Study Start

March 1, 2015

Primary Completion

May 1, 2017

Last Updated

December 15, 2015

Record last verified: 2015-12

Locations